Resultados de la búsqueda 231-240 of 9404 for 구글찌라시 を 17241833 を텔@adtopkingををSEO마케팅ををを텔@adtopkingををを구글키워드ををを

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same treatment plus ...

  2. Noticias - Centro Pediátrico de Mayo Clinic - Centro Pediátrico de Mayo Clinic

    News · mayo 2025 · enero 2025 · diciembre 2024 · noviembre 2024 · octubre 2024 · septiembre 2024 · agosto 2024 · julio 2024.

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate the safety and effectiveness of the da Vinci Surgical Systems in Nipple Sparing Mastectomy procedures. Assessing the ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    To evaluate the safety of multi-strain probiotic blend in cancer patients receiving ICIs. · To evaluate the clinical outcomes related to IIC, including the ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The pupose of this study is to evaluate whether or not selumetinib works just as well as the standard treatment with carboplatine/vincristine (CV) for ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. 99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer whose biopsy indicates ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This partially randomized clinical trial studies cholecalciferol in improving survival in patients with newly diagnosed cancer with vitamin D insufficiency.

  9. Radiología - Ensayos clínicos - Mayo Clinic

    The natural course of autosomal dominant polycystic kidney disease (ADPKD) is highly variable and typically characterized by progressive enlargement of cysts ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...